abstract |
The present disclosure comprises administering to a subject suffering from a tumor or cancer a therapeutically effective amount of an anti-TIM3 antibody alone or in combination with an inhibitor of the PD-1 signaling pathway (e.g., an anti-PD-1 antibody). Thus, a method of treating a subject suffering from a tumor or cancer is provided. In some embodiments, the antibody is administered as a flat dose or a weight-based dose. |